That high Eomes expression is increasingly observed in T cells at tumor sites and is positively correlated with increased survival in patients, suggests that its actions may go beyond promoting cytolytic activity in promoting CD4 T cell-mediated protection [109,113,114]. This evidence concerns the gene CD4 and neoplasm.